Nicardipine normalizes elevated levels of antioxidant activity in response to xanthine oxidase-induced oxidative stress in hypertensive rat heart

Free Radical Research

Volumn 29, Issue 2, 1998, Pages 143-150

  Carlos, D M ^a   Goto, S ^a   Urata, Y ^a   Iida, T ^a   Cho, S ^a   Niwa, M ^b   Tsuji, Y ^a   Kondo, T ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Glutathione; Heart; Nicardipine; SHR; Xanthine oxidase

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; MESSENGER RNA; NICARDIPINE; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ENZYME ACTIVITY; HEART WEIGHT; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; BLOTTING, NORTHERN; CALCIUM CHANNEL BLOCKERS; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HYPERTENSION; MALE; MYOCARDIUM; NICARDIPINE; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RNA, MESSENGER; XANTHINE OXIDASE;

EID: 0031712613     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715769800300161     Document Type: Article

References (36)

1. K. Nakazono, N. Watanabe, K. Matsuno, J. Sasaki, T. Sato and M. Inoue (1991) Does superoxide underlie the pathogenesis of hypertension? Proceeding of the National Academy of Sciences of the United States of America, 88, 10045-10048.
2. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel and W.P. Castelli (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New England Journal of Medicine, 322, 1561-1566.
3. Y.C. Zhu, Y.Z. Zhu, P. Gohlke, H.M. Stauss and T. Unger (1997) Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy. The American Journal of Cardiology, 80, 110-117.
4. Y.C. Zhu, Y.Z. Zhu, H. Spitznagel, P. Gohlke and T. Unger (1996) Substrate metabolism, hormone interaction, and angiotensin-converting enzyme inhibitors in left ventricular hypertrophy. Diabetes, 45, 59-65.
5. D.J. Sheridan, A. McAinsh and D.J. O'Gorman (1993) The coronary circulation in cardiac hypertrophy. Journal of Cardiovascular Pharmacology, 22, 18-28.
6. Y. Uehara, Y. Kawabata, H. Shirahase, K. Wada, Y. Hashizume, S. Morishita, A. Numabe and J. Iwai (1993) Oxygen radical scavengers and renal protection by indapamide diuretic in salt-induced hypertension of dahl strain rats. Journal of Cardiovascular Pharmacology, 22, 42-46.
7. L.S. Terada, D.M. Guidot, J.A. Leff, I.R. Willingham, M.E. Hanley, D. Piermattei and J.E. Repine (1992) Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proceeding of the National Academy of Sciences of the United States of America, 89, 3362-3366.
8. C. Cardillo, C.M. Kilcoyne, R.O. Cannon III, A.A. Quyyumi and J.A. Panza (1997) Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension, 30, 57-63.
9. Y. Miyamoto, T. Akaike, M. Yoshida, S. Goto, H. Horie and H. Maeda (1996) Potentiation of nitric oxide-mediated vasorelaxation by xanthine oxidase inhibitors. Proceedings of the Society for Experimental Biology and Medicine, 211, 366-373.
10. R Ferrari, C. Ceconi, S. Curello, C. Guarnieri, C.M. Caldarera, A. Albertini and O. Visioli (1985) Oxygen-mediated myocardial damage during ischaemia and reperfusion: Role of the cellular defenses against oxygen toxicity. Journal of Molecular and Cellular Cardiology, 17, 937-945.
11. M. Janssen, J.W. Jong, E. Pasini and R. Ferrari (1993) Myocardial xanthine oxidoreductase activity in hypertensive and hypercholesterolemic rats. Cardioscience, 4, 25-29.
12. A. Meister (1985) Methods for the selective modification of glutathione metabolism and study of glutathione transport. Methods in Enzymology, 113, 571-585.
13. G.F. Seelig, R.P. Simondsen and A. Meister (1984) Reversible dissociation of gamma-glutamylcysteine synthetase into two subunits. The Journal of Biological Chemistry, 259, 9345-9347.
14. N. Yan and A. Meister (1990) Amino acid sequence of rat kidney g-glutamylcysteine synthetase. The Journal of Biological Chemistry, 265, 1588-1593.
15. R.T. Mulcahy and J.J. Gipp (1995) Identification of a putative antioxidant response element in the 5′-flanking region of the human gamma-glutamylcysteine synthetase heavy subunit gene. Biochemical and Biophysical Research Communication, 209, 227-233.
16. Y. Urata, H. Yamamoto, S. Goto, H. Tsushima, S. Akazawa, S. Yamashita, S. Nagataki and T. Kondo (1996) Long exposure to high glucose concentration impairs the responsive expression of γ-glutamylcysteine synthetase by interleukin-1β and tumor necrosis factor-α in mouse endothelial cells. The Journal of Biological Chemistry, 271, 15146-15152.
17. T. Kondo, K. Yoshida, Y. Urata, S. Goto, S. Gasa and N. Taniguchi (1993) γ-Glutamylcysteine synthetase and active transport of glutathione S-conjugate are responsive to heat shock in K562 erythroid cells. The Journal of Biological Chemistry, 268, 20366-20372.
18. M. Ishibashi, S. Akazawa, H. Sakamaki, K. Matsumoto, H. Yamaguchi, S. Goto, Y. Urata, T. Kondo and S. Nagataki (1997) Oxygen-induced embryopathy and the significance of glutathione-dependent antioxidant system in the rat embryo during early organogenesis. Free Radical Biology and Medicine, 22, 447-454.
19. H. Kurokawa, T. Ishida, K. Nishio, H. Arioka, M. Sata, H. Fukumoto, M. Miura and N. Saijo (1995) Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance. Biochemical and Biophysical Research Communication, 216, 258-264.
20. A.P. Timerman, R.A. Altschuld, C.M. Hohl, G.P. Brierley and A.J. Merola (1990) Cellular glutathione and the response of adult rat heart myocytes to oxidant stress. Journal of Molecular and Cellular Cardiology, 22, 565-575.
21. H. Hong and P. Johnson (1995) Antioxidant enzyme activities and lipid peroxidation levels in exercised and hypertensive rat tissues. International Journal of Biochemistry and Biology, 27, 923-931.
22. I. Shou, L.N. Wang, Y. Takahashi, M. Fukui and Y. Tomino (1997) Effects of benidipine hydrochloride on antioxidant enzyme activity in stroke-prone spontaneous hypertensive rats (SHR-SP). Journal of Clinical Laboratory Analysis, 11, 158-162.
23. L.M. Bui, C.L. Keen and M.A. Dubick (1995) Comparative effects of 6-week nicotine treatment on blood pressure and components of the antioxidant system in male spontaneously hypertensive (SHR) and normotensive Wistar Kyoto (WKY) rats. Toxicology, 98, 57-65.
24. J.M. Brown, L.S. Terada, M.A. Grosso, G.J. Whitmann, S.E. Velasco, A. Patt, A.H. Harken and J.E. Repine (1988) Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. The Journal of Clinical Investigation, 81, 1297-1301.
25. E. Beutler (Ed.) (1984) A manual of biochemical methods, in: Red Cell Metabolism, 3rd edn., Philadelphia, Grune & Stratton, pp. 72-136.
26. J. Sambrook, E.F. Fritsch and T. Maniatis (1989) Molecular Cloning: A Laboratory Manual, 2nd edn., Cold spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 7-39.
27. H. Suzuki, A. Swei, B.W. Zweifach and G.W. Schmid-Schönbein (1995) In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hypertension, 25, 1083-1089.
28. A. Mülsch, J. Bauersachs, A. Schäfer, J.-P. Stasch, R. Kast and R. Busse (1997) Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. British Journal of Pharmacology, 120, 681-689.
29. T. Yamazaki, I. Komuro, S. Kudoh, Y. Zou, I. Shiojima, Y. Hiroi, T. Mizuno, K. Maemura, H. Kurihara, R. Aikawa, H. Takano and Y. Yazaki (1996) Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. The Journal of Biological Chemistry, 271, 3221-3228.
30. E.M. Sorkin and S.P. Clissold (1987) Nicardipine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Drugs, 33, 296-345.
31. K. Kumagai, H. Suzuki, M. Ichikawa, M. Jimbo, M. Nishizawa, M. Ryuzaki and T. Saruta (1996) Comparison of early and late start of antihypertensive agents and basoreceptor reflexes. Hypertension, 27, 209-218.
32. W.B. Weglicki, I.T. Mak and M.G. Simic (1990) Mechanisms of cardiovascular drugs as antioxidants. Journal of Molecular and Cellular Cardiology, 22, 1199-1208.
33. 2+-antagonists. Journal of Molecular and Cellular Cardiology, 20, 811-823.
34. E.-D. Jarasch, C. Bruder, G. Bruder, H.W. Heid, T.W. Keenan and W.W. Franke (1981) Localization of xanthine oxidase in mammary gland epithelium and capillary endothelium. Cell, 25, 67-82.
35. E.-D. Jarasch, G. Bruder and H.W. Heid (1986) Significance of xanthine oxidase in capillary endothelial cells. Acta Physiologica Scandinavica. Supplementum, 548, 39-46.
36. T. Adachi, T. Fukushima, Y. Usami and K. Hirano (1993) Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochemical Journal, 289, 523-527.